Works matching DE "NOTCH protein genetics"

Results: 2
    1
    2

    A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumours.

    Published in:
    British Journal of Cancer, 2014, v. 111, n. 10, p. 1932, doi. 10.1038/bjc.2014.497
    By:
    • Brana, I;
    • Siu, L L;
    • Almhanna, K;
    • Wenham, R M;
    • Gray, J E;
    • Sullivan, D M;
    • Dalton, W S;
    • Berger, R;
    • Golan, T;
    • Haluska, P;
    • Edenfield, J;
    • Stephenson, J;
    • Fiorica, J;
    • Martin, L P;
    • Westin, S;
    • Hanjani, P;
    • Jones, M B;
    • Gunchenko, A;
    • Cheng, J D
    Publication type:
    Article